Therapy Areas: Devices
Implantica's RefluxStop receives US FDA approval
21 August 2026 - Medical technology company Implantica AG (Nasdaq First North Premier Growth Market: IMP A SDB) announced on Thursday that the US Food and Drug Administration (FDA) has granted Premark...
Sectra to provide Education Portal to Loyalist College for medical imaging training
19 August 2026 - Sectra (STO: SECT B), a medical imaging IT and cybersecurity company, announced on Wednesday that it will provide its cloud-based Education Portal to Loyalist College in Ontario, Cana...
Aqua Medical treats second type 2 diabetes patient in IDE trial of investigational PIMA procedure
19 August 2026 - Aqua Medical Inc, a clinical-stage medical technology company advancing Endoscopic Metabolic Restoration, announced on Tuesday the treatment of the first West Coast patient (second ov...
Abbott and NACHC launch nationwide Food for Health initiative
18 August 2026 - American multinational medical devices and health care company Abbott (NYSE: ABT) and the National Association of Community Health Centers (NACHC) announced on Monday a multi-year �...
Galmed reports positive preclinical results for Aramchol in prostate cancer
17 August 2026 - Biopharmaceutical and medical device company Galmed Pharmaceuticals Ltd (NASDAQ: GLMD) on Monday reported preclinical results showing that Aramchol combined with enzalutamide produced...
Galderma receives EU approval for Restylane Shaype facial shaping injectable
11 August 2026 - Dermatology company Galderma (SWX:GALD) said on Tuesday that it has received European Union approval under the Medical Device Regulation for Restylane Shaype, a hyaluronic acid inject...